01626nam 2200409Ia 450 991069883370332120090526111323.0(CKB)5470000002397530(OCoLC)351422630(EXLCZ)99547000000239753020090526d2003 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry[electronic resource] revised recommendations for the assessment of donor suitability and blood product safety in cases of suspected severe acute respiratory syndrome (SARS) or exposure to SARSRockville, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,[2003]i, 9 pages digital, PDF fileTitle from PDF title page (viewed on May 26, 2009)."Final guidance"."September 2003".Includes bibliographical references (page 9).Guidance for industry Blood donorsGovernment policyUnited StatesBlood productsGovernment policyUnited StatesSARS (Disease)United StatesPreventionBlood donorsGovernment policyBlood productsGovernment policySARS (Disease)Prevention.Center for Biologics Evaluation and Research (U.S.)GPOGPOBOOK9910698833703321Guidance for industry3434577UNINA